Join Growin Stock Community!

強生4747.TW Overview

TW StockBiotech. & Medical
(No presentation for 4747)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

強生(4747)Overall Performance

強生(4747)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

強生(4747) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

強生(4747)Key Information

強生(4747)Profile

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.

強生(4747)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
40.49%
Net Margin
13.46%
Revenue Growth (YoY)
-7.94%
Profit Growth (YoY)
-5.81%
3-Year Revenue Growth
4.83%
3-Year Profit Growth
6.77%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
40.49%
Net Margin
13.46%
Revenue Growth (YoY)
-7.94%
Profit Growth (YoY)
-5.81%
3-Year Revenue Growth
4.83%
3-Year Profit Growth
6.77%
default symbol

4747

強生

56.80D

-0.18%

(-0.00)

  • When is 4747's latest earnings report released?

    The most recent financial report for 強生 (4747) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4747's short-term business performance and financial health. For the latest updates on 4747's earnings releases, visit this page regularly.

  • Where does 4747 fall in the P/E River chart?

    According to historical valuation range analysis, 強生 (4747)'s current price-to-earnings (P/E) ratio is 34.07, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4747?

    According to the latest financial report, 強生 (4747) reported an Operating Profit of 14.28M with an Operating Margin of 10.64% this period, representing a decline of 48.71% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4747's revenue growth?

    In the latest financial report, 強生 (4747) announced revenue of 134.26M, with a Year-Over-Year growth rate of -10.5%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4747 have?

    At the end of the period, 強生 (4747) held Total Cash and Cash Equivalents of 1.05B, accounting for 0.53 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4747 go with three margins increasing?

    In the latest report, 強生 (4747) achieved the “three margins increasing” benchmark, with a gross margin of 40.82%%, operating margin of 10.64%%, and net margin of 11.59%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4747's profit trajectory and future growth potential.

  • Is 4747's EPS continuing to grow?

    According to the past four quarterly reports, 強生 (4747)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.35. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4747?

    強生 (4747)'s Free Cash Flow (FCF) for the period is -26.23M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 7,436.49% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.